(Pakistan Diabetes Prevention Program PDPP) (PDPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01530165
Recruitment Status : Unknown
Verified January 2014 by Dr. Asma Ahmed, Aga Khan University.
Recruitment status was:  Active, not recruiting
First Posted : February 9, 2012
Last Update Posted : January 6, 2014
International Diabetes Federation
Helsinki University
Information provided by (Responsible Party):
Dr. Asma Ahmed, Aga Khan University

November 21, 2011
February 9, 2012
January 6, 2014
December 2011
October 2014   (Final data collection date for primary outcome measure)
Incidence of Type 2 Diabetes [ Time Frame: 2 yrs ]
Incidence of type 2 diabetes based on OGTT, diagnosed by WHO criteria at interim and end of an intervention.
Same as current
Complete list of historical versions of study NCT01530165 on Archive Site
  • Cost effectiveness [ Time Frame: 2 years ]
    Cost effectiveness by assessing the incremental costs and benefits per case of diabetes prevented and per quality adjusted life year (QALY).
  • Components of Metabolic syndrome [ Time Frame: 2 years ]
    To assess the difference in incidence of components of metabolic syndrom which includes waist circumference, dyslipidimia, blood pressure etc between control and intervention arm after 2 years of lifestyle intervention.
  • The impact of city planning on prevalence of obesity and type 2 diabetes [ Time Frame: 2 years ]
    The communities will be divided according to number and accessibility of parks. The community with large number of parks will be compared with community with no parks and then change in incidence of diabetes and obesity after 2 years of lifestyle intervention will be assessed and compared between two communities. By this it would be feasible to convince local authorities to incorporate this into their agenda for future urban design.
Same as current
Not Provided
Not Provided
(Pakistan Diabetes Prevention Program PDPP)
A Translation Randodomized Trial of Culturally Specific and Cost Effective Life Style Intervention for the Prevention of Type 2 Diabetes in Pakistan
The Karachi-based Pakistan Diabetes Prevention Study aims to address key issues in the prevention of type 2 diabetes. Approximately 20,000 people From four communities will be screened for diabetes risk factors using a non-invasive diabetes risk-score system. Those found to be at increased risk will be given an oral glucose tolerance test. People who, after the oral glucose tolerance test, are identified as having prediabetes will have the opportunity to take part in the Pakistan Diabetes Prevention Study lifestyle intervention. This consists of culturally adjusted preventive strategies focusing on diet and physical activity in real-life settings. Another important aspect of this trial will be to assess the impact of urban planning on the prevalence of obesity and diabetes.
Not Provided
Not Applicable
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Prediabetic State & High Risk Individuals
Behavioral: Life style counseling
The main goals of intervention will focus mainly on: Weight reduction ≥ 5% , moderate intensity physical activity ≥ 30 min daily, dietary fat <30 proportion of total energy, saturated fat <10%, Fiber ≥ 15g/1,000 kcal There will be 9 sessions during the two years course of follow-up
  • Standard
    Pre diabetics randomized to control arm will receive standard life style advice which is given to all pre diabetics seeking medical advice.
    Intervention: Behavioral: Life style counseling
  • Experimental: life style intervention arm
    This arm would be given aggressive life style intervention in comparison to standard (control) arm. The intervention would consist of nutritional and physical activity advice.
    Intervention: Behavioral: Life style counseling
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Unknown status
Same as current
October 2015
October 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

-Adult men and women between 30-64 years of age

Exclusion Criteria:

  • Diagnosed type 1 or type 2 diabetes
  • Pregnancy or presence of chronic disease rendering survival for three years unlikely
  • Any psychological or physical disability to interfere with participation in the study
  • Ischemic heart disease
Sexes Eligible for Study: All
30 Years to 64 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Dr. Asma Ahmed, Aga Khan University
Aga Khan University
  • International Diabetes Federation
  • Helsinki University
Principal Investigator: Asma Ahmed, MRCP(UK) The Aga Khan University Hospital
Principal Investigator: Jaweed Akhter, FRCP The Aga Khan University Hospital
Aga Khan University
January 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP